These findings are consistent with those of Liu et al., who investigated the expression of SBEM in 87 triple-negative breast cancer (TNBC) tissues using immunohistochemistry, where they observed positive expression of SBEM in 58% of patients and found that it was an independent prognostic marker of OS and DFS in TNBC patients [16]. The gene discussed is MUCL1; the disease is triple-negative breast carcinoma.